Indivisible Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Indivisible Partners's BMY Position: Q2 2026 in Review
Indivisible Partners increased its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, buying an estimated $68.6K and bringing the position to 11,646 shares worth $671K. The position accounts for 0.04% of the portfolio, ranked #314.
Indivisible Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Indivisible Partners held 11,646 shares of Bristol-Myers Squibb worth $671K as of Q2 2026.
- Indivisible Partners bought 1,195 Bristol-Myers Squibb shares in Q2 2026, an estimated $68.6K.
- Bristol-Myers Squibb made up 0.04% of Indivisible Partners's portfolio in Q2 2026, its #314 holding.
- Indivisible Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Indivisible Partners's 13F filing for Q2 2026, filed 4 Aug 2026.